Difluprednate API Quality, Stability and Worldwide Distribution

High-Purity Difluprednate API for Advanced Ophthalmic Formulations

Difluprednate Active Pharmaceutical Ingredient manufacturing demands strict quality control, advanced synthesis processes, and reliable regulatory documentation to ensure consistent therapeutic performance. As a potent corticosteroid API widely used in ophthalmic formulations, Difluprednate requires exceptional purity, particle size control, and chemical stability. Manufacturers must follow internationally accepted GMP standards while maintaining batch-to-batch consistency and impurity profiling within pharmacopeial limits. From raw material sourcing to final packaging, every stage is validated to meet global compliance expectations. High-grade production ensures safety, efficacy, and compatibility with complex formulations used in regulated pharmaceutical markets worldwide.

Name: Difluprednate

Synonyms: DFBA, Durezol, 6α,9α-Difluoroprednisolone-21-acetate-17-butyrate

CAS Number: 23674-86-4

Molecular Formula: C27H34F2O7

Molecular Weight: ≈ 508.55 g/mol

ATC Code: S01BA14 (ophthalmic corticosteroid)

API Grade: IP / BP / USP (pharmacopoeial standards)

DMF Availability: EU DMF, US DMF, JP DMF (depending on manufacturer)

🧪 Chemical & Physical Properties

  • Appearance: White to slightly yellow crystalline powder
  • Solubility: Practically insoluble in water; soluble in organic solvents like methanol, ethanol, acetonitrile
  • Melting Point: Approx. 191–195 °C
  • Storage: Typically 2–8 °C recommended for stability
  • Polymorphism: Exists in multiple crystalline forms important for formulation control

Quality Systems, Documentation & Regulatory Compliance

Comprehensive documentation forms the backbone of Difluprednate API supply. Leading manufacturers implement robust quality management systems supported by detailed Drug Master Files (DMF), Certificates of Analysis (CoA), stability data, impurity reports, and method validation records. Each batch undergoes stringent testing, including assay, related substances, residual solvents, and microbiological parameters. Regulatory-ready documentation helps partners streamline approvals across multiple regions and accelerates product registration timelines. Adherence to WHO-GMP, USFDA, MHRA, EMEA, and ANVISA standards further ensures acceptance in highly regulated markets. With traceability, risk assessment, and audit support, pharmaceutical companies gain confidence in reliable, compliant sourcing.

Amber Lifesciences Expertise & Global Supply Chain Strength

Amber Lifesciences stands out as a trusted partner in delivering premium Difluprednate API through a well-established global supply chain and advanced manufacturing infrastructure. The company emphasizes scalable production, controlled environments, and continuous process optimization to maintain consistent output and superior quality. Strategic sourcing networks and efficient logistics enable uninterrupted deliveries to customers across multiple countries. Backed by strong technical support and customized documentation assistance, Amber Lifesciences simplifies procurement for formulation companies and contract manufacturers. Their expertise in regulatory alignment, quality assurance, and international distribution ensures dependable supply, reduced lead times, and long-term business reliability for pharmaceutical partners worldwide.